{"title":"关节炎治疗的经济考虑","authors":"R. A. Zabinski","doi":"10.18553/JMCP.1999.5.6.476","DOIUrl":null,"url":null,"abstract":"iatroge.nic disease in patients with arthri- tis is substantial. In a population of Medicaid recipients, 25% of patients taking nonsteroidal antiinflammatory drugs (NSAlDs) experienced side effects that required further medical care. The costs of treating these side effects were accounted for primarily by drugs (42%) and physician visits (20%). However, hospitalization for complications, such as gastrointestinal (GO bleeding, per- foration, or obstruction, although un- common, accounted for 38% of iatro-","PeriodicalId":50156,"journal":{"name":"Journal of Managed Care Pharmacy","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2015-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Economic Considerations in the Management of Arthritis\",\"authors\":\"R. A. Zabinski\",\"doi\":\"10.18553/JMCP.1999.5.6.476\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"iatroge.nic disease in patients with arthri- tis is substantial. In a population of Medicaid recipients, 25% of patients taking nonsteroidal antiinflammatory drugs (NSAlDs) experienced side effects that required further medical care. The costs of treating these side effects were accounted for primarily by drugs (42%) and physician visits (20%). However, hospitalization for complications, such as gastrointestinal (GO bleeding, per- foration, or obstruction, although un- common, accounted for 38% of iatro-\",\"PeriodicalId\":50156,\"journal\":{\"name\":\"Journal of Managed Care Pharmacy\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Managed Care Pharmacy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18553/JMCP.1999.5.6.476\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Managed Care Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18553/JMCP.1999.5.6.476","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Economic Considerations in the Management of Arthritis
iatroge.nic disease in patients with arthri- tis is substantial. In a population of Medicaid recipients, 25% of patients taking nonsteroidal antiinflammatory drugs (NSAlDs) experienced side effects that required further medical care. The costs of treating these side effects were accounted for primarily by drugs (42%) and physician visits (20%). However, hospitalization for complications, such as gastrointestinal (GO bleeding, per- foration, or obstruction, although un- common, accounted for 38% of iatro-
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
